Approval · Notice of Compliance 8337 · 2006
NUVARING: Notice of Compliance 8337
Issued October 23, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8337
- Date
- October 23, 2006
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the product monograph
- Therapeutic class
- Contraceptive vaginal ring
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUVARING | Not yet assigned | — |
Medicinal ingredients
- ETONOGESTREL 11.4 MG per RING
- ETHINYL ESTRADIOL 2.6 MG per RING